Fax: +46-8-304571
Epidemiology
You have full text access to this OnlineOpen article
Milk, milk products and lactose intake and ovarian cancer risk: A meta-analysis of epidemiological studies
Article first published online: 28 JUL 2005
DOI: 10.1002/ijc.21305
Copyright © 2005 Wiley-Liss, Inc.
Additional Information
How to Cite
Larsson, S. C., Orsini, N. and Wolk, A. (2006), Milk, milk products and lactose intake and ovarian cancer risk: A meta-analysis of epidemiological studies. Int. J. Cancer, 118: 431–441. doi: 10.1002/ijc.21305
- †
Fax: +46-8-304571
Publication History
- Issue published online: 9 NOV 2005
- Article first published online: 28 JUL 2005
- Manuscript Accepted: 20 APR 2005
- Manuscript Received: 12 JAN 2005
Funded by
- Swedish Cancer Foundation
References
- 1. Lactase persistence and milk consumption as determinants of ovarian cancer risk. Am J Epidemiol 1989; 130: 904–10.
- 2, , , , , . The influence of lactose consumption on the association of oral contraceptive use and ovarian cancer risk. Am J Epidemiol 1991; 134: 445–53.
- 3, , . Adult hypolactasia, milk consumption, and age-specific fertility. Am J Epidemiol 1994; 139: 282–9.
- 4, , . Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort. Am J Clin Nutr 2004; 80: 1353–7.
- 5, . Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–88.
- 6, . Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992; 135: 1301–9.
- 7, . Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–58.
- 8, , . Systematic reviews in health care: meta-analysis in context. London: BMJ Publishing Group, 2001.
- 9, , , , , , . Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 1999; 149: 531–40.
- 10, , , . Lactose and benign ovarian tumours in a case-control study. Br J Cancer 2000; 83: 1552–5.
- 11, , , , , , , . A prospective study of dietary lactose and ovarian cancer. Int J Cancer 2004; 110: 271–7.
- 12, , , , , , . Prospective study of diet and ovarian cancer. Am J Epidemiol 1999; 149: 21–31.
- 13, , , , , , . Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States). Cancer Causes Control 2002; 13: 113–20.
- 14, . Dietary and other risk factors of ovarian cancer among elderly women. Jpn J Cancer Res 1988; 79: 997–1004.
- 15, , , . Risk factors for ovarian cancer in Taiwan: a case-control study in a low-incidence population. Gynecol Oncol 2003; 89: 318–24.
- 16, , , , . Nutritional determinants of epithelial ovarian cancer risk: a case-control study in Mexico. Oncology 2002; 63: 151–7.
- 17, , , , , , , , , . Association of dairy products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol 2002; 156: 148–57.
- 18, , , . Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr 2003; 133: 1937–42.
- 19, , , . Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada). Cancer Causes Control 1994; 5: 540–8.
- 20, , , , , , . Lactose and galactose intake and metabolism in relation to the risk of epithelial ovarian cancer. Am J Epidemiol 1995; 141: 407–16.
- 21, , , , . Dietary animal fat in relation to ovarian cancer risk. Obstet Gynecol 1984; 63: 833–8.
- 22, , , , , , , . Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet 1989; 2: 66–71.
- 23, , , , , , . A case-control study of galactose consumption and metabolism in relation to ovarian cancer. Cancer Epidemiol Biomarkers Prev 2000; 9: 95–101.
- 24, . A case-control study of milk-drinking and ovarian cancer risk. Am J Epidemiol 1990; 132: 871–6.
- 25, , . Nutritional risk factors and ovarian cancer. Nutr Cancer 1991; 15: 239–47.
- 26, , , , . Milk consumption, galactose metabolism and ovarian cancer (Australia). Cancer Causes Control 1998; 9: 637–44.
- 27, , , , , , . A population-based case-control study of carotenoid and vitamin A intake and ovarian cancer (United States). Cancer Causes Control 2001; 12: 83–90.
- 28, , , , , , , . Diet and ovarian cancer risk: a case-control study in Italy. Int J Cancer 2001; 93: 911–5.
- 29, , , . Diet and ovarian cancer risk: a case-control study in China. Br J Cancer 2002; 86: 712–7.
- 30, , , , . The Canadian Cancer Registries Epidemiology Research G. A case-control study of diet and the risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 1521–7.
- 31, , . Galactose metabolism and ovarian toxicity. Reprod Toxicol 2000; 14: 377–84.
- 32, , , , , . Dietary influences on survival after ovarian cancer. Int J Cancer 2003; 106: 264–9.
- 33, , . Intakes of selected nutrients and food groups and risk of ovarian cancer. Nutr Cancer 2001; 39: 19–28.
- 34, , , , , , , . Dietary fat intake and ovarian cancer in a cohort of US women. Am J Epidemiol 2002; 156: 22–31.
- 35, , , Dietary fat intake and risk of epithelial ovarian cancer. J Natl Cancer Inst 1994; 86: 1409–5.
- 36, , , , , , . Ovarian cancer, cholesterol, and eggs: a case-control analysis. Cancer Epidemiol Biomarkers Prev 2002; 11: 1112–4.
- 37, . Galactose inhibition of ovulation in mice. Fertil Steril 1988; 49: 522–6.
- 38, . Molecular basis of galactosemia: mutations and polymorphisms in the gene encoding human galactose-1-phosphate uridylyltransferase. Proc Natl Acad Sci USA 1991; 88: 2633–7.
- 39, , , , , . Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 1981; 304: 994–8.
- 40, , , . Correlation of ovarian function with galactose-1-phosphate uridyl transferase levels in galactosemia. J Pediatr 1988; 112: 754–6.
- 41, , , , . Mutation of galactose-1-phosphate uridyl transferase and its association with ovarian cancer and endometriosis. Int J Cancer 1998; 77: 825–7.
- 42, , , , , , , , . Association of galactose-1-phosphate uridyltransferase activity and N314D genotype with the risk of ovarian cancer. Am J Epidemiol 2002; 156: 693–701.
- 43, , , . Functional analysis of the human galactose-1-phosphate uridyltransferase promoter in Duarte and LA variant galactosemia. Mol Genet Metab 2001; 72: 297–305.
- 44, , , , . Molecular basis for Duarte and Los Angeles variant galactosemia. Am J Hum Genet 1997; 60: 366–72.

1097-0215/asset/olbannerleft.jpg?v=1&s=45719cd7de57873027993264fcc568b335a8cd56)
1097-0215/asset/olbannerright.jpg?v=1&s=5e0fba63c1309b3036eb9215a0e1e83dd02efd19)
